Rights and Permissions
Massalska M, Ciechomska M, Kuca-Warnawin E, Burakowski T, Kornatka A, Radzikowska A, Pawlak D, Muz B, Loniewska-Lwowska A, Palucha A, Maldyk P, Maslinski W. Effectiveness of Soluble CTLA-4-Fc in the Inhibition of Bone Marrow T-Cell Activation in Context of Indoleamine 2.3-Dioxygenase (IDO) and CD4+Foxp3+ Treg Induction. J Inflamm Res. 2022 Dec 22;15:6813-6829. doi: 10.2147/JIR.S359775.
© 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Massalska, Magdalena; Ciechomska, Marzena; Kuca-Warnawin, Ewa; Burakowski, Tomasz; Kornatka, Anna; Radzikowska, Anna; Pawlak, Dariusz; Muz, Barbara; Loniewska-Lwowska, Adrianna; Palucha, Andrzej; Maldyk, Pawel; and Maslinski, Wlodzimierz, "Effectiveness of soluble CTLA-4-Fc in the inhibition of bone marrow T-cell activation in context of indoleamine 2.3-dioxygenase (IDO) and CD4+Foxp3+ Treg induction." Journal of Inflammation Research. 15, 6813 - 6829. (2022).